Exelixis Inc Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Exelixis Inc (EXEL) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-20.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2014-02-20
- Exelixis Inc incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2013 was 0.00 shares.
- Exelixis Inc incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2012 was 0.00 shares, a 100.00% decline from fiscal 2011.
- Exelixis Inc incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2011 was 1.86M shares.
- Exelixis Inc incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2010 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|
| 2013-12-31 | 0.00 shares 10-K · filed 2014-02-20 |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-02-20 |
| 2011-12-31 | 1.86M shares 10-K · filed 2014-02-20 |
| 2010-12-31 | 0.00 shares 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |